Acute pulmonary edema (APE) is a common Emergency Department (ED) presentat
ion requiring admission to an intensive care unit (ICU), This study was und
ertaken to examine the effect of ED management on the need for ICU admissio
n in patients with APE. ED records of APE patients were abstracted for pati
ent age, prehospital and ED pharmacological treatment, diagnoses, airway in
terventions, and ICU length of stay (LOS). Statistical analysis was through
multiple regression, logistic regression, chi-square, and ANOVA, One hundr
ed eighty one patients composed the study group, Pharmacological treatment
included nitroglycerin (NTG), 147 patients (81%); morphine sulfate (MS), 88
(49%); loop diuretics (LD), 133 (73%); and captopril sublingual (CSL), 47
(26%), Use of CSL and MS were associated with opposing needs for ICU admiss
ion, MS use was associated with increased ICU admissions (odds ratio, 3.08;
P = .002), whereas CSL use was associated with decreased ICU admissions (o
dds ratio, 0.29; P = .002), Morphine sulfate use also demonstrated an in cr
eased need for endotracheal intubation (ETI) (odds ratio, 5.04; P = .001),
whereas CSL demonstrated a decreased need for ETI (odds ratio, 0.16; P = .0
08). Ninety-three patients required some form of respiratory support. Forty
received noninvasive pressure support ventilation (NPSV) from a bilevel po
sitive airway pressure system (BiPAP), and 60 received endotracheal intubat
ion. Some patients received more than 1 form of respiratory support; all ot
her patients received supplemental oxygen only, The ICU-LOS associated with
different airway interventions were supplemental oxygen, 0.72 days; BiPAP,
1.48 days; and ETI, 3.70 days (P < .001), Specific ED pharmacological inte
rventions are associated with a decreased need for ICU admission and endotr
acheal intubation in acute pulmonary edema patients, whereas use of noninva
sive pressure support ventilation correlates with a reduction in the ICU le
ngth of stay for patients who do require critical care admission, (C) 1999
by W.B. Saunders Company.